49 results
Search Results
2. Effect of daidzein on CYP1A2 activity and pharmacokinetics of theophylline in healthy volunteers
3. Dose dependent pharmacokinetics of theophylline: Michaelis-menten parameters for its major metabolic pathways
4. Influence of hepatic regeneration after partial hepatectomy on theophylline pharmacokinetics in rats
5. Influence of gatifloxacin, a new quinolone antibacterial, on pharmacokinetics of theophylline
6. Theophylline kinetics in peripheral tissues in vivo in humans
7. Theophylline pharmacokinetics and metabolism in rabbits following single and repeated administration ofCapsicum fruit
8. Kinetic interaction between theophylline and a newly developed anti-allergic drug, pemirolast potassium
9. Lack of effect of magnesium-aluminium hydroxide on the absorption of theophylline given as a pH-dependent sustained release preparation
10. Neonatal theophylline intoxication: Pharmacokinetics and clinical evaluation
11. Theophylline and ethylenediamine pharmacokinetics following administration of aminophylline to septic patients with multiorgan failure
12. Effect of mequitazine on the pharmacokinetics of theophylline in asthmatic patients
13. Age related differences in plasma theophylline levels
14. Influence of the menstrual cycle on theophylline pharmacokinetics in asthmatics
15. Influence of hyperlipidic food on the kinetics of slow-release formulations of theophylline
16. Pharmacokinetics of theophylline in young children with asthma: Comparison of rectal enema and suppositories
17. Disposition and clinical pharmacokinetics of theophylline after administration of a new sustained release tablet
18. Effect of chronic oral contraceptive steroids on theophylline disposition
19. The pharmacokinetics of theophylline and enprofylline in patients with liver cirrhosis and in patients with chronic renal disease
20. Enoxacin — a potent inhibitor of theophylline metabolism
21. Enprofylline: Pharmacokinetics and comparison with theophylline of acute effects on bronchial reactivity in normal subjects
22. Pharmacokinetics of diuretics and methylxanthines in the neonate
23. Greatly enhanced bioavailability of theophylline on postprandial administration of a sustained release tablet
24. Comparison of single and multiple dose pharmacokinetics of theophylline using stable isotopes
25. Intravenous administration of enprofylline to asthmatic patients
26. Pharmacokinetics of theophylline in infants with bronchiolitis
27. Pharmacokinetics of theophylline in hyperthyroid and hypothyroid patients with chronic obstructive pulmonary disease
28. Bioavailability and pharmacokinetics of theophylline in plain uncoated and sustained-release dosage forms in relation to smoking habit I. Single dose study
29. Longitudinal effects of pregnancy on the pharmacokinetics of theophylline
30. A comparison of the pharmacokinetics of theophylline in asthmatic children in the acute episode and in remission
31. Theophylline pharmacokinetics following single and repeated administration of slow-release capsules
32. A “once a day administration” sustained-release theophylline formulation: Disposition and pharmacokinetics
33. Methods of comparing pharmacokinetics of slow release preparations: a comparison of “Theo-Dur” and “Phyllocontin” in patients with asthma
34. Pharmacokinetics of theophylline and its metabolites in rabbits
35. Chronopharmacology and its application to the development of theophylline treatment schedules for asthma
36. Felodipine reduces the absorption of theophylline in man
37. Increased theophylline clearance in asthmatic patients due to terbutaline
38. The interaction of erythromycin with theophylline
39. Lack of clinically important interaction between erythromycin and theophylline
40. Pharmacokinetics of theophylline in Ethiopian children of differing nutritional status
41. Creation of four consecutive instantaneous steady-state plasma concentration plateaus of theophylline and enprofylline by repeated infusions with exponentially decreasing delivery rates
42. Disposition and clinical pharmacokinetics of microcrystalline theophylline
43. Pharmacokinetics of theophylline in patients following short-term intravenous infusion
44. Circadian changes in the absorption and elimination of theophylline in patients with bronchial obstruction
45. Individualizing theophylline dosage: Evaluation of a single-point maintenance dose prediction method
46. Effect of miocamycin on theophylline kinetics in children
47. Pharmakokinetik und Pharmakodynamik von Theophyllin bei multimorbiden geriatrischen Patienten
48. Total theophylline clearance in childhood: the influence of age-dependent changes in metabolism and elimination
49. Personality and theophylline pharmacokinetics
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.